Opening book details…
About this Medicine article
Updated Overall Survival (Os) from the Phase 3 Trial, Ca184-043: Ipilimumab (Ipi) Vs Placebo (Pbo) in Patients with Post-Docetaxel Metastatic Castration-Resistant Prostate Cancer (Mcrpc) by Fizazi, K. ;Drake, C.G. ;Kwon, E.D. ;Bossi, A. ;van den Eertwegh, A.J. ;Scher, H.I. ;Beer, T.M. ;McHenry, M.B. ;Liu, D. ;Gerritsen, W.R. ;Logothetis, C. is a Medicine article available to read on EtoBox.
It is typically read by researchers, students, and practitioners in Medicine.
- Author
- Fizazi, K. ;Drake, C.G. ;Kwon, E.D. ;Bossi, A. ;van den Eertwegh, A.J. ;Scher, H.I. ;Beer, T.M. ;McHenry, M.B. ;Liu, D. ;Gerritsen, W.R. ;Logothetis, C.
- Publisher
- Oxford University Press; Elsevier BV (ISSN 0923-7534)
- Published
- 2014
- Language
- EN
- Field
- Medicine (Health Sciences)